52 related articles for article (PubMed ID: 2380098)
1. Determinants of drug response in a cisplatin-resistant human lung cancer cell line.
Fujiwara Y; Sugimoto Y; Kasahara K; Bungo M; Yamakido M; Tew KD; Saijo N
Jpn J Cancer Res; 1990 May; 81(5):527-35. PubMed ID: 2116401
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of cisplatin sensitivity in high mobility group 2 cDNA-transfected human lung cancer cells.
Arioka H; Nishio K; Ishida T; Fukumoto H; Fukuoka K; Nomoto T; Kurokawa H; Yokote H; Abe S; Saijo N
Jpn J Cancer Res; 1999 Jan; 90(1):108-15. PubMed ID: 10076573
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin-DNA adduct repair of transcribed genes is controlled by two circadian programs in mouse tissues.
Yang Y; Adebali O; Wu G; Selby CP; Chiou YY; Rashid N; Hu J; Hogenesch JB; Sancar A
Proc Natl Acad Sci U S A; 2018 May; 115(21):E4777-E4785. PubMed ID: 29735688
[TBL] [Abstract][Full Text] [Related]
4. Active efflux system for cisplatin in cisplatin-resistant human KB cells.
Fujii R; Mutoh M; Niwa K; Yamada K; Aikou T; Nakagawa M; Kuwano M; Akiyama S
Jpn J Cancer Res; 1994 Apr; 85(4):426-33. PubMed ID: 8200854
[TBL] [Abstract][Full Text] [Related]
5. Impact of fractionated cisplatin and radiation treatment on cell growth and accumulation of DNA damage in two normal cell types differing in origin.
Akuwudike P; López-Riego M; Dehours C; Lundholm L; Wojcik A
Sci Rep; 2023 Sep; 13(1):14891. PubMed ID: 37689722
[TBL] [Abstract][Full Text] [Related]
6. Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer.
Wang S; Zhang H; Scharadin TM; Zimmermann M; Hu B; Pan AW; Vinall R; Lin TY; Cimino G; Chain P; Vuyisich M; Gleasner C; Mcmurry K; Malfatti M; Turteltaub K; de Vere White R; Pan CX; Henderson PT
PLoS One; 2016; 11(1):e0146256. PubMed ID: 26799320
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia.
Takagi K; Kawai Y; Yamauchi T; Iwasaki H; Ueda T
Int J Hematol; 2011 Oct; 94(4):378-389. PubMed ID: 21948264
[TBL] [Abstract][Full Text] [Related]
8. Radiation- and chemoinduced multidrug resistance in colon carcinoma cells.
Bartkowiak D; Stempfhuber M; Wiegel T; Bottke D
Strahlenther Onkol; 2009 Dec; 185(12):815-20. PubMed ID: 20013091
[TBL] [Abstract][Full Text] [Related]
9. Response of cyclin B1 to ionizing radiation: regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD.
Ozeki M; Tamae D; Hou DX; Wang T; Lebon T; Spitz DR; Li JJ
Anticancer Res; 2004; 24(5A):2657-63. PubMed ID: 15517870
[TBL] [Abstract][Full Text] [Related]
10. The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients.
Ghazal-Aswad S; Hogarth L; Hall AG; George M; Sinha DP; Lind M; Calvert AH; Sunter JP; Newell DR
Br J Cancer; 1996 Aug; 74(3):468-73. PubMed ID: 8695367
[TBL] [Abstract][Full Text] [Related]
11. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content.
Eichholtz-Wirth H; Reidel G; Hietel B
Br J Cancer; 1993 May; 67(5):1001-6. PubMed ID: 8494693
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivo.
Eichholtz-Wirth H; Hietel B
Br J Cancer; 1994 Oct; 70(4):579-84. PubMed ID: 7522509
[TBL] [Abstract][Full Text] [Related]
14. Treatment of DNA with ammonium bicarbonate or thiourea can lead to underestimation of platinum-DNA monoadducts.
Gibbons GR; Page JD; Chaney SG
Cancer Chemother Pharmacol; 1991; 29(2):112-6. PubMed ID: 1760852
[TBL] [Abstract][Full Text] [Related]
15. An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts.
Szymkowski DE; Yarema K; Essigmann JM; Lippard SJ; Wood RD
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10772-6. PubMed ID: 1438274
[TBL] [Abstract][Full Text] [Related]
16. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.
Hill BT; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Bedford P
Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):75-83. PubMed ID: 2380098
[TBL] [Abstract][Full Text] [Related]
17. Differential formation and enhanced removal of specific cisplatin-DNA adducts in two cisplatin-selected resistant human testicular teratoma sublines.
Hill BT; Shellard SA; Fichtinger-Schepman AM; Schmoll HJ; Harstrick A
Anticancer Drugs; 1994 Jun; 5(3):321-8. PubMed ID: 7919457
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the unusual expression of cross resistance to cisplatin in a series of etoposide-selected resistant sublines of the SuSa testicular teratoma cell line.
Shellard SA; Hosking LK; Hill BT
Biochem Pharmacol; 1994 Mar; 47(5):775-9. PubMed ID: 8135853
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
